Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming

Laura Loges, Michael Gabel, Annkathrin Knauss, Raja Atreya, Arne Gessner, Nora Bartels, Markus F Neurath, Benno Weigmann

Open source

DOI
10.1093/jimmun/vkag175
Published
2026-07
Container
The Journal of Immunology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jimmun/vkag175,
  title = {Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming},
  author = {Laura Loges and Michael Gabel and Annkathrin Knauss and Raja Atreya and Arne Gessner and Nora Bartels and Markus F Neurath and Benno Weigmann},
  year = {2026},
  journal = {The Journal of Immunology},
  doi = {10.1093/jimmun/vkag175},
  url = {https://doi.org/10.1093/jimmun/vkag175}
}

RIS

TY  - JOUR
TI  - Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming
AU  - Laura Loges
AU  - Michael Gabel
AU  - Annkathrin Knauss
AU  - Raja Atreya
AU  - Arne Gessner
AU  - Nora Bartels
AU  - Markus F Neurath
AU  - Benno Weigmann
PY  - 2026
JO  - The Journal of Immunology
DO  - 10.1093/jimmun/vkag175
UR  - https://doi.org/10.1093/jimmun/vkag175
ER  - 

APA

Loges, L., Gabel, M., Knauss, A., Atreya, R., Gessner, A., Bartels, N., Neurath, M. F., & Weigmann, B. (2026). Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag175

Source records